Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
13.74
-1.44 (-9.49%)
At close: Oct 9, 2026, 4:00 PM EDT
13.82
+0.08 (0.58%)
After-hours: Oct 9, 2026, 4:10 PM EDT
Eloxx Pharmaceuticals Market Cap
Eloxx Pharmaceuticals has a market cap or net worth of $55.46 million as of October 9, 2026. It is the 29,683rd most valuable company in the world and the 4,594th biggest in the United States.
Market Cap
55.46M
Enterprise Value
5.33M
1-Year Change
n/a
Global Rank
Country Rank
#4,594 United States
Category
ChartMarket Cap Chart
Since May 17, 2002, Eloxx Pharmaceuticals's market cap has increased from $38.20M to $55.46M, an increase of 45.19%. That is a compound annual growth rate of 1.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 55.46M | - |
| Dec 31, 2025 | - | - |
| Dec 31, 2024 | - | -100.00% |
| Dec 29, 2023 | 3.80M | -2.56% |
| Dec 30, 2022 | 3.90M | -93.60% |
| Dec 31, 2021 | 60.90M | -61.89% |
| Dec 31, 2020 | 159.80M | -45.72% |
| Dec 31, 2019 | 294.40M | -30.20% |
| Dec 31, 2018 | 421.80M | 1,947.57% |
| Dec 29, 2017 | 20.60M | 610.34% |
| Dec 30, 2016 | 2.90M | -64.63% |
| Dec 31, 2015 | 8.20M | -28.07% |
| Dec 31, 2014 | 11.40M | -40.00% |
| Dec 31, 2013 | 19.00M | 1.60% |
| Dec 31, 2012 | 18.70M | -10.95% |
| Dec 30, 2011 | 21.00M | 10.53% |
| Dec 31, 2010 | 19.00M | 126.19% |
| Dec 31, 2009 | 8.40M | -49.40% |
| Dec 31, 2008 | 16.60M | 30.71% |
| Dec 31, 2007 | 12.70M | -34.54% |
| Dec 29, 2006 | 19.40M | -13.78% |
| Dec 30, 2005 | 22.50M | -54.36% |
| Dec 31, 2004 | 49.30M | 20.83% |
| Dec 31, 2003 | 40.80M | 57.53% |
| Dec 31, 2002 | 25.90M | -32.20% |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 62.89M |
| Pliant Therapeutics | 61.92M |
| Adicet Bio | 61.79M |
| Alps Group | 61.45M |
| Gossamer Bio | 60.43M |
| RenovoRx | 60.02M |
| Mereo BioPharma Group | 59.92M |
| Kalaris Therapeutics | 59.51M |